Speaker Profile
Ph.D., VP, BMS
Biography
Richard Hargreaves is a neuroscientist with a BSc and Ph.D. from Chelsea/Kings College, London University UK, currently serving as Senior VP Head of Neuroscience, Immunology, Integrative Sciences and Cardiovascular research at Bristol Myers Squibb. His career also includes leadership roles at Celgene, Biogen, and Merck where his teams contributed to the development and registration of multiple CNS drugs and PET imaging agents. Richard has also played key roles in building external partnerships, collaborations and strategic acquisitions in neuroscience. His work has been recognized through various scientific and leadership awards and an honorary professorship at the University of Oxford UK.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Alex Morgan, Khosla Ventures & Gad Getz, Broad Institute
PMWC Award Ceremony
• David Baker, University of Washington (Nobel Laureate, Luminary)
Featured Speakers
• David Baker, University of Washington
• Jack Dent, Chai Discovery
• Dimitri Yatsenko, DataJoint
• Evgeny Kiner, Neosplice Therapeutics
• Alex Morgan, Khosla Ventures
• Gad Getz, Broad Institute
Causal Targets, Not Just Better Molecules
Using AI and human biology to improve target selection before chemistry begins.
Data Is the Moat
What proprietary, longitudinal, and perturbational data really confer advantage.
From Prediction to Patient
Patient stratification, smarter trials, and the handoff from model to clinic.
Designed Biology Meets Drug Development
AI-designed proteins, developability, and what survives contact with reality.
The Target Discovery Bottleneck
Why splicing and other underused biology may expand what is druggable.
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
